SEM Company Profile and Key Details

Short-term trend indicators are bearishly aligned (SMA20 -3.84%, SMA50 -2.24%, SMA200 4.59%). The stock’s 14-day RSI is 39.89 (weak momentum), while the ATR of 0.38 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -23.09% below its high and over 28.07% above its low. Average 10-day trading volume of 2.27 million shares is significantly above the 3-month average of 1.00 million, indicating heightened recent market interest.

Select Medical Holdings Corporation generated EPS of $1.16 over the past year. Five-year average earnings growth is -9.58%. Wall Street analysts project EPS growth of 6.32% annually over the next five years. The latest quarter delivered EPS of $0.23. The next quarter is forecast at $0.45. Next year's EPS is expected at $14.50. Analyst sentiment is bullish. Analyst rating data shows there are 3 Strong Buy ratings, 1 Buy ratings, 2 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $20.00 to $14.00. The high target offers 23.0% upside. The low target suggests -13.9% downside. The mean target is $17.83. This offers 9.66% upside. Select Medical Holdings Corporation earnings surprise history is a mixed track record. The quarter that ended October 30, 2025, missed forecasts by 27.78%. The prior quarter beat by 14.29%. Over the last six quarters, Apple has recorded several small beats. These include 1.69% in August 01, 2024.

Select Medical Holdings Corporation last paid a dividend of 0.25 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $32.47. This means the shares are trading below this model’s fair value.

Select Medical Holdings Corporation has 123.99 million shares outstanding. The public float is 104.59 million shares, elevated short interest at 5.95% of float. This equals 3.13 million shares. The short ratio is 3.33 days. Institutional investors hold 99.04% of the float. Insiders own 15.68%. ORTENZIO ROCCO A holds 5.32 million shares, JACKSON MARTIN F has 1.04 million shares and CHERNOW DAVID S has 714.52 thousand shares.

Select Medical Holdings Corporation (NYSE:SEM) closed at $16.26 USD, gaining $1.26 (8.40%) from the previous close of $15.00. The stock is currently mid-range between its 52-week high and low $11.65 and $18.61. With a market capitalization of about $2.02 billion, Select Medical Holdings Corporation is classified as a mid-cap and shows market-like volatility (beta ~0.96). Key stats such as the average daily volume over the past year has been around 894.43 thousand shares, trading with heavier-than-usual volume. Headquartered in Mechanicsburg, PA, Select Medical Holdings Corporation operates in the Healthcare sector and the Medical - Care Facilities industry. Led by CEO Thomas Mullin, the company employs approximately 30,000 people and listed since September 25, 2009. Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States.

Select Medical Holdings Corporation trades at a P/E ratio of 13.73, slightly below the S&P 500 average, with a price-to-sales ratio of 0.37 and a price-to-book ratio of 1.18 suggesting the stock is closer to book value. The P/FCF stands at 17.2, also above market averages.

Our AI price prediction model suggests that Select Medical Holdings Corporation stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -12.36%, with price expected at $14.25 by March 17, 2026, within a range of $13.76 to $14.71 3-Month Outlook: Projected fall of -14.76%, reaching $13.86 by May 28, 2026, with a range of $13.34 to $14.31. 1-Year Outlook: Projected loss of -3.01%, with price at $15.77 by March 03, 2027, within a range of $15.00 to $16.82.

Select Medical Holdings Corporation (NYSE:SEM) shares are flat 2.36% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Select Medical Holdings Corporation trading at a premium to the broader market with a P/E of 13.73. Analyst sentiment is cautious, with the majority of ratings in Sector Perform territory and a mean price target of $28.10, suggesting 72.82% upside. Our AI forecast model points to short-term weakness (-12.36% over two weeks), a medium-term fall (-14.76% over three months), and a longer-term loss (-3.01% over one year), with expected trading ranges indicating moderate volatility.